Household transmission of the human gut microbiota after antibiotic exposure
接触抗生素后人类肠道微生物群的家庭传播
基本信息
- 批准号:10593834
- 负责人:
- 金额:$ 31.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-11-07 至 2024-10-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAffectAntibioticsAutologousCiprofloxacinCollectionCommunitiesDataDietEnvironmentEventExclusionFecesFutureGoalsHouseholdHumanIndividualMapsMetabolicMicrobeMolecularMutationNutrientOutcomePredictive FactorProbioticsResearchResourcesRoleShapesSiteStructureSystemTaxonomyTestingWorkcohortdesigndosageexperimental studyfecal transplantationfeedinggut microbiomegut microbiotain vivoinsightmetagenomic sequencingmicrobialmicrobial colonizationmicrobial communitymicrobiomemicrobiome therapeuticsnovelrecruitresidencestool samplesuccesstheoriestransmission process
项目摘要
PROJECT SUMMARY/ABSTRACT
Humans constantly encounter microbes in their diets and environments, but only a tiny fraction of these
microbes take up long-term residence in the adult gut microbiome. Microbiome therapeutics like probiotics and
fecal microbiota transplants often seek to introduce new, desirable microbes, but these strains are frequently
lost and fail to stably colonize existing communities. Understanding the ecological interactions that affect
colonization and transmission is crucial for designing successful targeted microbiome therapeutics. Ecological
theory predicts that factors like cross-feeding, nutrient competition, and priority effects may affect the ability of
new microbes to colonize established communities, but there remain few examples of ecological interactions
that affect colonization in the human gut microbiome. Here, we propose to investigate ecological interactions in
microbial communities that affect colonization and transmission in natural and experimental gut microbial
communities. We plan to focus on households, which are natural settings of microbial transmission. We have
already recruited a longitudinal household cohort to document transmission after antibiotic exposure in the adult
gut microbiome which allows us to determine how disturbances affect strain colonization. We will also use a
novel experimental system to test the role of ecological factors like community diversity, ecological drift, and
environmental perturbations. First, we will track transmission events within households in the human gut
microbiome after antibiotic exposure by performing metagenomic sequencing of stool samples from the
household cohort. By analyzing these data, we will identify transmission events that occur before and after
antibiotic exposure, and we will track the trajectories of mutations that arise after strain transmission, as strains
propagate in new hosts and communities. Next, we will characterize the effects of ecological drift and community
diversity on transmission in ex vivo microbial communities. We have generated ex vivo communities from stool
samples collected from our household cohort, and we will mix pairs of communities to evaluate the effects of
strain dosage and community diversity on transmission. Finally, we will systematically mix ex vivo communities
to identify strains capable of colonizing communities before and after antibiotic perturbation. Together, this work
will provide important new information about the ecological factors that shape microbial colonization and
transmission. The initial, exploratory work proposed here will also pave the way for future work that uses these
collections of gut-derived communities to identify and characterize molecular and metabolic interactions between
strains that affect microbial colonization, helping us design more effective, targeted microbiome therapeutics.
项目概要/摘要
人类在饮食和环境中不断遇到微生物,但只占其中的一小部分
微生物在成人肠道微生物组中长期居住。微生物疗法,如益生菌和
粪便微生物群移植通常试图引入新的、理想的微生物,但这些菌株经常被
迷失并且无法稳定地殖民现有社区。了解影响的生态相互作用
定植和传播对于设计成功的靶向微生物组疗法至关重要。生态的
理论预测,交叉喂养、营养竞争和优先效应等因素可能会影响
新的微生物在已建立的群落中定居,但生态相互作用的例子仍然很少
影响人类肠道微生物组的定植。在这里,我们建议研究生态相互作用
影响自然和实验肠道微生物定植和传播的微生物群落
社区。我们计划重点关注家庭,这是微生物传播的自然环境。我们有
已经招募了一个纵向家庭队列来记录成人接触抗生素后的传播情况
肠道微生物组使我们能够确定干扰如何影响菌株定植。我们还将使用一个
新颖的实验系统,用于测试群落多样性、生态漂移等生态因素的作用
环境扰动。首先,我们将追踪家庭内人类肠道内的传播事件
通过对粪便样本进行宏基因组测序来暴露抗生素后的微生物组
家庭队列。通过分析这些数据,我们将识别之前和之后发生的传输事件
抗生素暴露,我们将追踪菌株传播后出现的突变轨迹,如菌株
在新的宿主和社区中传播。接下来,我们将描述生态漂移和群落的影响
离体微生物群落传播的多样性。我们从粪便中产生了离体群落
从我们的家庭队列中收集样本,我们将混合成对的社区来评估
菌株剂量和群落多样性对传播的影响。最后,我们将系统地混合离体社区
以确定在抗生素干扰之前和之后能够在群落中定殖的菌株。共同完成这项工作
将提供有关影响微生物定植的生态因素的重要新信息
传播。这里提出的初步探索性工作也将为使用这些的未来工作铺平道路
肠道衍生群落的集合,用于识别和表征之间的分子和代谢相互作用
影响微生物定植的菌株,帮助我们设计更有效、更有针对性的微生物疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID A. RELMAN其他文献
DAVID A. RELMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID A. RELMAN', 18)}}的其他基金
Microbial dispersal, skin-to-skin contact, and assembly of the neonatal gut microbiome
微生物扩散、皮肤接触以及新生儿肠道微生物组的组装
- 批准号:
10178070 - 财政年份:2020
- 资助金额:
$ 31.03万 - 项目类别:
Antimicrobial Resistance and Horizontal Gene Transfer in the Human Gut Microbiome in Response to an Antibiotic
人类肠道微生物组对抗生素的耐药性和水平基因转移
- 批准号:
10176389 - 财政年份:2020
- 资助金额:
$ 31.03万 - 项目类别:
Antimicrobial Resistance and Horizontal Gene Transfer in the Human Gut Microbiome in Response to an Antibiotic
人类肠道微生物组对抗生素的耐药性和水平基因转移
- 批准号:
10404963 - 财政年份:2020
- 资助金额:
$ 31.03万 - 项目类别:
Antimicrobial Resistance and Horizontal Gene Transfer in the Human Gut Microbiome in Response to an Antibiotic
人类肠道微生物组对抗生素的耐药性和水平基因转移
- 批准号:
10624323 - 财政年份:2020
- 资助金额:
$ 31.03万 - 项目类别:
Integration of Microbe and Host Data Diagnosis of Febrile Illness
热病微生物与宿主数据融合诊断
- 批准号:
9241962 - 财政年份:2014
- 资助金额:
$ 31.03万 - 项目类别:
Environmental Arsenic Exposure, Microbiome, and Human Health
环境砷暴露、微生物组和人类健康
- 批准号:
8889677 - 财政年份:2014
- 资助金额:
$ 31.03万 - 项目类别:
Environmental Arsenic Exposure, Microbiome, and Human Health
环境砷暴露、微生物组和人类健康
- 批准号:
9113017 - 财政年份:2014
- 资助金额:
$ 31.03万 - 项目类别:
Environmental Arsenic Exposure, Microbiome, and Human Health
环境砷暴露、微生物组和人类健康
- 批准号:
8606066 - 财政年份:2014
- 资助金额:
$ 31.03万 - 项目类别:
Environmental Arsenic Exposure, Microbiome, and Human Health
环境砷暴露、微生物组和人类健康
- 批准号:
8889677 - 财政年份:2014
- 资助金额:
$ 31.03万 - 项目类别:
相似国自然基金
基于真菌的跨界群体感应干扰对水环境抗生素抗性基因传播的影响及调控研究
- 批准号:42307159
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人工补给对地下水抗生素抗性组与病原菌的影响及调控机制
- 批准号:42377392
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
过氧乙酸/亚硫酸盐体系降解内酰胺类抗生素作用机制及对氯化消毒副产物的影响与控制
- 批准号:52370009
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
多环芳烃影响大肠杆菌抗生素耐药性进化的分子机制
- 批准号:32301424
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
排水管网沉积物中抗生素对功能菌降解PAHs的影响机制
- 批准号:
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:
相似海外基金
Patient reported outcomes in patients with nontuberculous mycobacterial pulmonary disease
非结核分枝杆菌肺病患者报告的结果
- 批准号:
10720789 - 财政年份:2023
- 资助金额:
$ 31.03万 - 项目类别:
Koli: A non-surgical solution for gallstone disease
Koli:胆结石疾病的非手术解决方案
- 批准号:
10698949 - 财政年份:2023
- 资助金额:
$ 31.03万 - 项目类别:
Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy
CD19 靶向 CAR-T 细胞治疗后的免疫球蛋白替代疗法和感染并发症
- 批准号:
10732195 - 财政年份:2023
- 资助金额:
$ 31.03万 - 项目类别:
Development of a Novel Animal Model for Spinal Cord Injury with Sepsis
脓毒症脊髓损伤新型动物模型的开发
- 批准号:
10665862 - 财政年份:2023
- 资助金额:
$ 31.03万 - 项目类别:
Diagnostic and treatment landscape of pyoderma gangrenosum
坏疽性脓皮病的诊治现状
- 批准号:
10732688 - 财政年份:2023
- 资助金额:
$ 31.03万 - 项目类别: